26 March 2018

TIKOMED CEO IS PANELIST AT EUROPE CEO IN AMSTERDAM

TikoMeds CEO represented TikoMed at the Europe CEO meeting prior to the BIO Europe spring event.
The panel discussed the topic of how to build a biotech company in Europe. Several parts of the structural process was touched upon but in essence the panelists concurred that people, in every aspect is the essence. The chain from founders, owners, board, management and staff needs to be crisp, diligent and professional. In turn that will provide for efficient positioning, funding, strategy and execution of plans.

DATE
TBA

TIME
TBA

VENUE
TBA

OTHER NEWS

5 July 2018
Tikomed granted permission for clinical trial in ALS by the Swedish Medical Product Agency and Ethical Review Board.
Viken, May 28th, 2018 TikoMed, a specialty pharmaceutical company focused on developing therapeutics for treating…
Read More
5 July 2018
ILB – A game changer in Glaucoma
Viken, May 22nd, 2018 TikoMed, a specialty pharmaceutical company that focuses on developing therapeutics for…
Read More
5 June 2018
Anders Kristensson appointed CEO of TikoMed
Viken – 18th June 2018 TikoMed, a privately-held biopharmaceutical company today announced the appointment of…
Read More
SEE MORE